Cell Reports · 2023 · 17 citations · 57 references
MedicineImmunologyOncologyCancer ImmunologyImmunoregulationTumor MicroenvironmentAntitumor T Cell ResponsesCancer ImmunotherapyCell-mediated ImmunityCytokine BiologyImmune ResponseInterferon ResponsesAdoptive Cell Therapy ImmunologyAntitumor Cytokine ResponsesCytokine-mediated T Cell ActivationCytokine-mediated T Cell ResponsesPro-tumorigenic SignalingTh1 Immune ResponseTherapeutic Efficacy AssessmentTumor Microenvironment Effects
Interleukin (IL)-6 is abundantly expressed in the tumor microenvironment and is associated with poor patient outcomes. Here, we demonstrate that the deletion of the suppressor of cytokine signaling 3 (SOCS3) in T cells potentiates anti-tumor immune responses by conferring the anti-tumorigenic function of IL-6 in mouse and human models. In Socs3 -deficient CD8 + T cells, IL-6 upregulates the expression of type I interferon (IFN)-regulated genes and enhances the anti-tumor effector function of T cells, while also modifying mitochondrial fitness to increase mitochondrial membrane potential and reactive oxygen species (ROS) levels and to promote metabolic glycolysis in the energy state. Furthermore, Socs3 deficiency reduces regulatory T cells and increases T helper 1 (Th1) cells. SOCS3 knockdown in human chimeric antigen receptor T (CAR-T) cells exhibits a strong anti-tumor response in humanized mice. Thus, genetic disruption of SOCS3 offers an avenue to improve the therapeutic efficacy of adoptive T cell therapy.
57
Integrated analysis of multimodal single-cell data
Yuhan Hao, Stephanie Hao, Erica Andersen‐Nissen et al. · Cell · 2021 · 16K citations · Full text
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou, Bin Zhou, Lars Pache et al. · Nature Communications · 2019 · 15.6K citations · Full text
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih‐Hao Chang, Jonathan D. Curtis, Leonard B. Maggi et al. · Cell · 2013 · 2.2K citations · Full text